NAFLD can progress to nonalcoholic steatohepatitis and then to HCC, and T2DM increases the risk of HCC by a factor of 3 through the PTEN/P13K/Akt and MAPK kinase molecular pathway [3–5]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.